antibody-drug binding technology

Kepco Engineering & Construction Co. has teamed up with South Korea's defense company Terra Defense to establish a system aimed at protecting nu...

South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...

South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...

Samsung Electronics Co. and LG Electronics Inc. are vying for the North American market for air conditioners with their cutting-edge solutions in th...

South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...

Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...

Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US,  has applied to the Australian clini...

In a first for shipbuilding, South Korea's Samsung Heavy Industries has developed a system to confirm all data generated in the process of shipbuild...

Woowa Brothers, the parent company of South Korea's food delivery app Baedal Minjok, on Wednesday spun off its professional service robot unit into ...

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...

A research team at South Korea's top science and technology university has developed an anti-drone technology that can remotely neutralize a city-in...

South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...

A self-driving vehicle taking a passenger home and then docking into the building so that they can enter the house without being exposed to the outs...

South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...

South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

POSCO Chemical Co., a unit of South Korean steelmaker POSCO Holdings Co., on Thursday won government approval to transfer technology to its overseas...

South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...

South Korea's No. 1 secondary battery maker LG Energy Solution Ltd. and Seoul National University on Friday signed an agreement to establish an indu...

South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...

ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...

South Korea's major shipbuilder Samsung Heavy Industries said on Thursday that it has signed an agreement with MISC Berhad, a Malaysian offshore ene...

GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...

Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...

South Korea's construction engineering company Kolon Global Corp. said on Monday that it has obtained a technology patent for the multi-purpose syst...

Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...

Cosmax, a cosmetics original design manufacturer (ODM) of South Korea, said on Tuesday that it unveiled the beauty technology developed jointly ...

Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...